APA (7th ed.) Citation

Yu, M., Lin, A., Baharom, F., Li, S., Legendre, M., Covés-Datson, E., . . . Smed-Sörensen, A. (2025). A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion. PLoS Pathogens, 21(5), e1013112. https://doi.org/10.1371/journal.ppat.1013112

Chicago Style (17th ed.) Citation

Yu, Meng, et al. "A Genetically Engineered Therapeutic Lectin Inhibits Human Influenza A Virus Infection and Sustains Robust Virus-specific CD8 T Cell Expansion." PLoS Pathogens 21, no. 5 (2025): e1013112. https://doi.org/10.1371/journal.ppat.1013112.

MLA (9th ed.) Citation

Yu, Meng, et al. "A Genetically Engineered Therapeutic Lectin Inhibits Human Influenza A Virus Infection and Sustains Robust Virus-specific CD8 T Cell Expansion." PLoS Pathogens, vol. 21, no. 5, 2025, p. e1013112, https://doi.org/10.1371/journal.ppat.1013112.